no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Ablation versus Anti-Arrhythmic Therapy for Reducing All Hospital Episodes from Recurrent Atrial Fibrillation (AVATAR-AF): Design and rationale
|
Mann, Ian |
|
|
214 |
C |
p. 36-45 |
article |
2 |
A protocol update of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 trial: A comparison of fractional flow reserve–guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease
|
Zimmermann, Frederik M. |
|
|
214 |
C |
p. 156-157 |
article |
3 |
Assessing cardiac safety in oncology drug development
|
Seltzer, Jonathan H |
|
|
214 |
C |
p. 125-133 |
article |
4 |
Canadian-Australasian Randomised trial of screening kidney transplant candidates for coronary artery disease—A trial protocol for the CARSK study
|
Ying, Tracey |
|
|
214 |
C |
p. 175-183 |
article |
5 |
Creatinine versus cystatin C to estimate glomerular filtration rate in adults with congenital heart disease: Results of the Boston Adult Congenital Heart Disease Biobank
|
Opotowsky, Alexander R. |
|
|
214 |
C |
p. 142-155 |
article |
6 |
De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health status
|
Qintar, Mohammed |
|
|
214 |
C |
p. 1-8 |
article |
7 |
Editorial Board
|
|
|
|
214 |
C |
p. v |
article |
8 |
Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF)
|
Lindenfeld, JoAnn |
|
|
214 |
C |
p. 18-27 |
article |
9 |
Hospital participation in clinical trials for patients with acute myocardial infarction: Results from the National Cardiovascular Data Registry
|
Fanaroff, Alexander C. |
|
|
214 |
C |
p. 184-193 |
article |
10 |
Information for Readers
|
|
|
|
214 |
C |
p. vi |
article |
11 |
Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States
|
Gaziano, Thomas A. |
|
|
214 |
C |
p. 77-87 |
article |
12 |
Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina (ORBITA) and coronary stents: A case study in the analysis and reporting of clinical trials
|
Gelman, Andrew |
|
|
214 |
C |
p. 54-59 |
article |
13 |
Outcomes of left main revascularization in patients with acute coronary syndromes and stable ischemic heart disease: Analysis from the EXCEL trial
|
Doucet, Serge |
|
|
214 |
C |
p. 9-17 |
article |
14 |
Participation in thrill-seeking activities by patients with hypertrophic cardiomyopathy: Individual preferences, adverse events and physician attitude
|
Papoutsidakis, Nikolaos |
|
|
214 |
C |
p. 28-35 |
article |
15 |
Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry
|
Nanna, Michael G. |
|
|
214 |
C |
p. 113-124 |
article |
16 |
Racial differences in long-term outcomes among black and white patients with drug-eluting stents
|
Sullivan II, Lonnie T. |
|
|
214 |
C |
p. 46-53 |
article |
17 |
Rational and design of the INtentional COronary revascularization versus conservative therapy in patients undergOing successful peripheRAl arTEry revascularization due to critical limb ischemia trial (INCORPORATE trial)
|
Toth, G. |
|
|
214 |
C |
p. 107-112 |
article |
18 |
Rationale and design of DanGer shock: Danish-German cardiogenic shock trial
|
Udesen, Nanna Junker |
|
|
214 |
C |
p. 60-68 |
article |
19 |
Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy
|
Kedhi, Elvin |
|
|
214 |
C |
p. 134-141 |
article |
20 |
Rationale and design of the PRAETORIAN-DFT trial: A prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing
|
Quast, Anne-Floor B.E. |
|
|
214 |
C |
p. 167-174 |
article |
21 |
Risk factors and prognostic impact of left ventricular assist device–associated infections
|
Tattevin, Pierre |
|
|
214 |
C |
p. 69-76 |
article |
22 |
Role of diabetes and insulin use in the risk of stroke and acute myocardial infarction in patients with atrial fibrillation: A Medicare analysis
|
Mentias, Amgad |
|
|
214 |
C |
p. 158-166 |
article |
23 |
Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trial
|
Alexandre, Joachim |
|
|
214 |
C |
p. 88-96 |
article |
24 |
Table of Contents
|
|
|
|
214 |
C |
p. i-iv |
article |
25 |
Twenty-year trends in profile, management and outcomes of patients with ST-segment elevation myocardial infarction according to use of reperfusion therapy: Data from the FAST-MI program 1995-2015
|
Puymirat, Etienne |
|
|
214 |
C |
p. 97-106 |
article |